Wockhardt Limited (WOCKPHARMA) announces Rs. 73 Cr PAT for Q2 FY27, with revenue growth of 24% and strong biotech operations.
Granules India Limited (GRANULES) reports Q2FY27 results with revenue up 20% YoY, EBITDA up 21%, and PAT up 39%.
Procter & Gamble Health Limited (PGHL) reports a 18% sales increase and a 26% rise in PAT for Q2 FY27, driven by strong brand fundamentals.
Narayana Hrudayalaya Ltd. (NH) reports a 10.6% PAT increase and 73% YoY revenue surge in Q2 FY27, showcasing robust financial performance.
Hikal Limited (NSE: HIKAL) signs a multi-year global CDMO contract with a leading agrochemical company, marking a key milestone for its Crop Protection busin.
Sai Parenterals Limited (SAIPARENT) Q2 FY27 results show revenue up 9% QoQ, PAT grows 32.7% QoQ, ahead of FY27 targets.
Rainbow Childrens Medicare Limited (RAINBOW) reports Q2FY27 earnings with a 23% revenue increase and an 11% rise in PAT.
Narayana Hrudayalaya Ltd. announces Q2 FY27 results with consolidated revenue up 73.0% YoY and EBITDA up 42.0% YoY.
CORONA Remedies Limited (CORONA) reports highest ever revenue with 22% growth for Q2FY27 on Y-o-Y basis, outperforming IPM.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Venetoclax Tablets, 10 mg, 50 mg, and 100 mg, expanding its generic drug portfolio.